Bayer Appoints Rachana Panda VP, Country Head for Communications, Public Affairs and Sustainability for South Asia

Bayer has appointed Rachana Panda as Vice- President and Country Head for Communications, Public Affairs and Sustainability for South Asia. As a member of Bayer’s South Asia Leadership Team, she will work across all of Bayer’s businesses in the region, in addition to collaborating with global teams to provide impetus to the group’s multiple initiatives in India.

D. Narain, Senior Bayer Representative for South Asia and Vice Chairman & Managing Director for Bayer CropScience Limited said, “At Bayer, we continue to build on our long legacy of over 100 years as a trusted partner for both India and South Asia. As we work towards delivering on our vision of ‘Health for all, hunger for none’, we are delighted to welcome Rachana on board. With her vast experience across sectors, she will play a pivotal role in enabling Bayer achieve its commitments to support society and business growth in the region.“

In her earlier role, Rachana was the Chief Communications Officer for GE South Asia. Over her career, she has also worked with companies such as Alstom, Alcatel and UTStarcom. 

Rachana Panda said, “I am excited to join Bayer with its rich legacy globally of translating its vision to reality for the benefit of society at large. I look forward to playing an integral part in this growth journey.”

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.